Skip to content

Engineered immune cells yield “unprecedented” results in early cancer trials

February 17, 2016

Researchers are reporting a significant advance in using immunotherapy to fight cancer, with early experiments using the technique on advanced blood cancer patients producing “unprecedented” response rates of more than 93 percent.

Sourced through from:

Knocking back blood cancers with immunotherapy could be a real life saver for many people.

See on Scoop.itLong Life

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: